Inflammatory bowel diseases (IBDs), represented by Crohn disease and ulcerative colitis,
are associated with major morbidity in Western countries and with increasing incidence in …

The role of the gut microbiome in models of inflammatory and autoimmune disease is now
well characterized. Renewed interest in the human microbiome and its metabolites, as well …

Introduction The ESPEN guideline presents a multidisciplinary focus on clinical nutrition in
inflammatory bowel disease (IBD). Methodology The guideline is based on extensive …

Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the
gastrointestinal tract, characterized by an inflammatory process that requires lifelong …

Recent advances in basic and clinical science over the last 3 years have dramatically
altered our appreciation of the role of diet in inflammatory bowel diseases (IBD). The marked …

Recent evidence points to a plausible role of diet and the microbiome in the pathogenesis of
both Crohn's disease (CD) and Ulcerative Colitis (UC). Dietary therapies based on exclusion …

Diet has an important role in the development of colorectal cancer. In the past few decades,
findings from extensive epidemiologic and experimental investigations have linked …

Inflammatory bowel diseases are common, complex, immune-mediated conditions with a
sharply rising global prevalence. While major advances since 2000 have provided strong …

Crohn's disease (CD) and ulcerative colitis (UC) are chronic, relapsing, inflammatory
disorders of the digestive tract that characteristically develop in adolescence and early …

Background & Aims It is not clear how the complex interactions between diet and the
intestinal microbiota affect development of mucosal inflammation or inflammatory bowel …